Zack’s Small Cap raises price target again on BSEM: a rising medtech stock

Growing revenues has led to another price target increase for this biotech company Growing revenues has led to another price target increase for this biotech company                                                                                                      You are receiving this email because you are subscribed to Morning Watchlist from Behind the Markets. If you no longer wish to receive these partner emails, please [unsubscribe]( here. This message is from Huge Alerts. --------------------------------------------------------------- [BSEM, a rising MedTech firm, just received another price increase from Zack’s Small Cap Research to $23.25!]( [bsem stock]( The MedTech sector is often overlooked but is just as innovative as many of the top tech names. Two massive multi-billion-dollar markets for its regenerative therapies position [BioStem Technologies Inc. (OTC: BSEM)]( as one a top medtech stock to watch. The medtech arena is not the easiest to navigate given how many kinds of companies are in it. It’s all about finding emerging players like [BSEM]( who have successfully navigated the regulatory process (a real barrier to entry) and show real growth. Zack’s Small Cap Research recently increased its price target to $23.25, recognizing the company’s value after it reported Q1 financial results. “We reiterate our belief the BSEM is still underpriced even after its recent move higher and continues to represent a good opportunity at recent prices for investors to get in before what we believe will be a more aggressive move higher in the not-too-distant future. The vision management has for the company’s products and the focus they are using to deliver results are encouraging and are now being rewarded by increased demand. As such, we suggest investors with a modestly higher risk tolerance take a look at BSEM,” said Zack’s Small Cap Research in a report. 2023 was a pivotal year for BSEM which has established a solid foundation for the company's future expansion, which now includes a potential uplisting to a senior stock exchange. After a year that was marked by robust revenue growth, BSEM is navigating 2024 for another year of success. There could be an uplisting to a senior exchange on the horizon! As regenerative medicine continues to find its way into the mainstream, emerging biotech company [BioStem Technologies, Inc. (OTC: BSEM)]( is making waves for its focus on harnessing elements of perinatal tissue derived from the human placenta for manufacturing structural tissue allografts to heal wounds. [Learn more about why Zack’s has increased its price target on BSEM to $23.25!]( Our mailing address is: Behind the Markets, LLC 4260 NW 1st Avenue, Suite 55 Boca Raton, FL 33431 We are issuing this disclosure in compliance with Section 17(b) of the Securities Act, which requires us to disclose any compensation received or expected to be received in cash or in kind in connection with the purchase or sale of any security. We would like to inform you that we have received or expect to receive compensation in connection with the purchase or sale of the securities of BioStem Technologies Inc. (OTC: BSEM). The compensation consists of up to $2,500 and was received/will be received from Sideways Frequency. This compensation should not be considered as an endorsement of the securities of adviser BioStem Technologies Inc. (OTC: BSEM) and we are not responsible for any errors or omissions in any information provided about the securities of BioStem Technologies Inc. (OTC: BSEM). We encourage you to conduct your own due diligence and research before making any investment decisions. You should also consult with a financial advisor before making any investment decisions. This disclosure is made as of 5/28/24. Copyright © 2024 Behind the Markets, LLC, All rights reserved. You're receiving this email as part of your subscription to Behind the Markets. For more information about our privacy practices, please review our [Privacy Policy]( or our [Legal Notices.]( [Unsubscribe](